Login / Signup

Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis.

Dou DouZe-Yu ZhangZhi-Yuan WuXu-Dong QiuXiang-Gen Zhong
Published in: Evidence-based complementary and alternative medicine : eCAM (2020)
TCMIs combined with systemic chemotherapy could be an effective and safe treatment option for patients with HCC. Kanglaite injection showed a tendency to be better than the other two kinds of injections in terms of ORR. Nevertheless, additional results from multicentre trials and high-quality studies will be pivotal for supporting our findings.
Keyphrases
  • ultrasound guided
  • locally advanced
  • squamous cell carcinoma
  • randomized controlled trial
  • cross sectional
  • study protocol
  • hepatitis c virus
  • combination therapy
  • platelet rich plasma